首页> 外国专利> SUSTAINED RELEASE FILM PREPARATION FOR LOCAL ADMINISTRATION COMPRISING PROSTAGLANDIN DERIVATIVE AS ACTIVE INGREDIENT

SUSTAINED RELEASE FILM PREPARATION FOR LOCAL ADMINISTRATION COMPRISING PROSTAGLANDIN DERIVATIVE AS ACTIVE INGREDIENT

机译:包含前列腺素衍生物作为活性成分的局部给药的持续释放膜制备

摘要

A persistent filmy preparation which comprises methyl(11.alpha.,13E,15.alpha.)-9-oxo-11,15-dihydroxy-16-(3-methoxymethylphenyl)-17,18,19,20-tetranor-5-thiaprost-13-enoate represented by the formula (I): (I)or a nontoxic salt thereof as an active ingredient and a bioabsorbable polymeras a substrate and which is for use in topical administration to a sicklocation where the bone amount is small; and a remedy for bone amountreduction which comprises the persistent filmy preparation. The persistentfilmy preparation, which contains the compound (I) as an active ingredient,promotes bone formation upon topical administration and is useful fortreatments for bone amount reduction.
机译:包含甲基的持久性薄膜制剂(11α,13E,15α。)-9-氧代-11,15-二羟基-16-(3-甲氧基甲基苯基)-由式(I)表示的17,18,19,20-四氟-5-硫杂脯氨酸-13-烯酸酯:或其无毒盐作为有效成分和可生物吸收的聚合物作为基质,用于局部给药于患者骨量少的部位和骨量的补救办法减少,包括持久的薄膜准备。持久的含有化合物(I)作为有效成分的薄膜状制剂,局部给药可促进骨骼形成,对减少骨量的治疗方法。

著录项

  • 公开/公告号CA2467061A1

    专利类型

  • 公开/公告日2003-05-22

    原文格式PDF

  • 申请/专利权人 ONO PHARMACEUTICAL CO. LTD.;

    申请/专利号CA20022467061

  • 发明设计人 TABATA YASUHIKO;NISHIURA AKIO;

    申请日2002-07-22

  • 分类号A61K31/5575;A61P19/00;A61P1/02;A61P19/02;A61P35/04;A61P19/08;A61P19/10;A61P3/14;A61K9/70;

  • 国家 CA

  • 入库时间 2022-08-21 23:58:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号